Neurocrine Biosciences
NBIX
#1689
Rank
A$18.21 B
Marketcap
A$181.52
Share price
-1.13%
Change (1 day)
-4.19%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company